Literature DB >> 34180017

ASO Author Reflections: Pathologic Response Ratio (PRR) in CRS and HIPEC for Peritoneal Metastasis from Colorectal Cancer.

Eyal Mor1, Shachar Laks2, Aviram Nissan2, Mohammad Adileh2.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 34180017     DOI: 10.1245/s10434-021-10369-4

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  4 in total

1.  Correlation Between Intraoperative and Pathological Findings for Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.

Authors:  Y Berger; H Jacoby; M I Kaufmann; A Ben-Yaacov; G Westreich; I Sharon; L Barda; N Sharif; R Nadler; N Horesh; A Nissan; M Gutman; A Hoffman
Journal:  Ann Surg Oncol       Date:  2019-02-11       Impact factor: 5.344

2.  Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database.

Authors:  Jan Franko; Qian Shi; Jeffrey P Meyers; Timothy S Maughan; Richard A Adams; Matthew T Seymour; Leonard Saltz; Cornelis J A Punt; Miriam Koopman; Christophe Tournigand; Niall C Tebbutt; Eduardo Diaz-Rubio; John Souglakos; Alfredo Falcone; Benoist Chibaudel; Volker Heinemann; Joseph Moen; Aimery De Gramont; Daniel J Sargent; Axel Grothey
Journal:  Lancet Oncol       Date:  2016-10-12       Impact factor: 41.316

3.  Linear Relationship of Peritoneal Cancer Index and Survival in Patients with Peritoneal Metastases from Colorectal Cancer.

Authors:  Matthieu Faron; Raluca Macovei; Diane Goéré; Charles Honoré; Léonor Benhaim; Dominique Elias
Journal:  Ann Surg Oncol       Date:  2015-05-27       Impact factor: 5.344

4.  Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.

Authors:  Vic J Verwaal; Serge van Ruth; Eeclo de Bree; Gooike W van Sloothen; Harm van Tinteren; Henk Boot; Frans A N Zoetmulder
Journal:  J Clin Oncol       Date:  2003-10-15       Impact factor: 44.544

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.